Biotech
Regulatory
Sanofi’s Dupixent (dupilumab) Receives European Commission Approval for Severe Asthma
Shots: The approval is based on LIBERTY ASTHMA program including two P-III (QUEST and VENTURE) & one P-IIb studies assessing Dupixent + SOC vs PBO in 2,888 adults and adolescents […]readmore